GB0617865D0 - Novel use - Google Patents

Novel use

Info

Publication number
GB0617865D0
GB0617865D0 GBGB0617865.1A GB0617865A GB0617865D0 GB 0617865 D0 GB0617865 D0 GB 0617865D0 GB 0617865 A GB0617865 A GB 0617865A GB 0617865 D0 GB0617865 D0 GB 0617865D0
Authority
GB
United Kingdom
Prior art keywords
novel use
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0617865.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0617865.1A priority Critical patent/GB0617865D0/en
Publication of GB0617865D0 publication Critical patent/GB0617865D0/en
Priority to PCT/EP2007/059473 priority patent/WO2008031799A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
GBGB0617865.1A 2006-09-11 2006-09-11 Novel use Ceased GB0617865D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0617865.1A GB0617865D0 (en) 2006-09-11 2006-09-11 Novel use
PCT/EP2007/059473 WO2008031799A1 (en) 2006-09-11 2007-09-10 Use of piperazine compounds for the treatment of neurodegenerative diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0617865.1A GB0617865D0 (en) 2006-09-11 2006-09-11 Novel use

Publications (1)

Publication Number Publication Date
GB0617865D0 true GB0617865D0 (en) 2006-10-18

Family

ID=37232740

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0617865.1A Ceased GB0617865D0 (en) 2006-09-11 2006-09-11 Novel use

Country Status (2)

Country Link
GB (1) GB0617865D0 (en)
WO (1) WO2008031799A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018005713A1 (en) * 2016-06-29 2018-01-04 Congxin Liang Piperazine derivatives as trpml modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL163608A0 (en) * 2002-02-28 2005-12-18 Univ Temple Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
BRPI0513713A (en) * 2004-07-28 2008-05-13 Glaxo Group Ltd piperazine derivatives useful for the treatment of gastrointestinal disorders

Also Published As

Publication number Publication date
WO2008031799A1 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
EP2089034A4 (en) Novel uses
DE602007002700D1 (en) Interventionsfreies frac-system
EP2078282A4 (en) E-couponing
EP2033216A4 (en) Electroadhesion
DE602007008085D1 (en) Dihydropyrazolopyrimidinonderivate
DE602007014031D1 (en) Luftreifensatz
DE602007002070D1 (en) 2-pyrazincarboxamidderivate
DE602007003855D1 (en) Isothermer reaktor
EP1983992A4 (en) 2-imino-benzimidazoles
DE602007001601D1 (en) Glasuntersuchung
DE602007006989D1 (en) Spiropiperidinderivate
GB0605107D0 (en) Use
AP2008004724A0 (en) Substituted1-yl)-azolin-2-aryl-1-hetaryl-ethane
DE602007011622D1 (en) Penem-prodrugs
EP2084019A4 (en) Paintscraper
GB0624105D0 (en) Use
EP2024567A4 (en) Earthen-wallpaper
GB0621229D0 (en) Novel use
EP2007388A4 (en) Opiopathies
AP2009004788A0 (en) Novel use
DK1989111T3 (en) Satellitluftbremseapparat
EP1974618A4 (en) Innerwear
GB0617865D0 (en) Novel use
GB0603087D0 (en) Novel use
DE502007001126D1 (en) Eiten

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)